LIVINGSTON; Brian D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LIVINGSTON; Brian D..The latest application filed is for "toxoplasma gondii vaccines and their use".

Company Profile

4.7.19

LIVINGSTON; Brian D. - La Jolla CA
Livingston; Brian D. - San Diego CA
Livingston; Brian D. - Martinez CA
Livingston, Brian D - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Toxoplasma Gondii Vaccines And Their Use App 20200289629 - MCLEOD; Rima ; et al.	2020-09-17
Toxoplasma Gondii Vaccines And Their Use App 20190282679 - MCLEOD; Rima ; et al.	2019-09-19
Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid Compositions App 20160193316 - Sette; Alessandro ; et al.	2016-07-07
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions Grant 9,266,930 - Sette , et al. February 23, 2	2016-02-23
Compositions And Methods Of Making And Using Influenza Proteins App 20130089596 - Van Nest; Gary ; et al.	2013-04-11
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions App 20110097352 - Sette; Alessandro ; et al.	2011-04-28
Optimized multi-epitope constructs and uses thereof Grant 7,888,472 - Sette , et al. February 15, 2	2011-02-15
Optimized Multi-Epitope Constructs and Uses Thereof App 20100068218 - SETTE; Alessandro ; et al.	2010-03-18
Method and System for Optimizing Minigenes and Peptides Encoded Thereby App 20100049491 - SETTE; Alessandro ; et al.	2010-02-25
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions App 20090311283 - Sette; Alessandro ; et al.	2009-12-17
Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions App 20090304746 - Sette; Alessandro ; et al.	2009-12-10
Composition And Methods Of Making And Using Influenza Proteins App 20090196915 - VAN NEST; Gary ; et al.	2009-08-06
Optimized multi-epitope constructs and uses thereof Grant 7,507,803 - Sette , et al. March 24, 2	2009-03-24
Method and system for optimizing minigenes and peptides encoded thereby Grant 7,462,354 - Sette , et al. December 9, 2	2008-12-09
Methods of identifying optimal variants of peptide epitopes App 20070054262 - Baker; Denise M. ; et al.	2007-03-08
Optimized multi-epitope constructs and uses thereof App 20070048330 - Sette; Alessandro ; et al.	2007-03-01
Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions App 20050271676 - Sette, Alessandro ; et al.	2005-12-08
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions App 20050063983 - Sette, Alessandro ; et al.	2005-03-24
Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby App 20040248113 - Sette, Alessandro ; et al.	2004-12-09
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions Grant 6,689,363 - Sette , et al. February 10, 2	2004-02-10
Method and system for optimizing minigenes and peptides encoded thereby App 20020119127 - Sette, Alessandro ; et al.	2002-08-29
DNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptides Grant 5,750,395 - Fikes , et al. May 12, 1	1998-05-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.